SCHEMBL19675441

SCHEMBL19675441

Cc1cc(CC(=O)ON)ccc1Br

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.43
RIN1 Q13671 1/20 0.43
ALDH1A1 P00352 4/20 0.41
GAA P10253 2/20 0.41
GFER P55789 1/20 0.41
KMT2A Q03164 4/20 0.40
MEN1 O00255 2/20 0.40
RAB9A P51151 3/20 0.39
PKM P14618 1/20 0.39
MAPT P10636 4/20 0.39
TDP1 Q9NUW8 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
NPC1 O15118 2/20 0.37
POLB P06746 2/20 0.37
KDM4E B2RXH2 1/20 0.37
FFAR4 Q5NUL3 1/20 0.36
ALKBH5 Q6P6C2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14712149 0.85 ALDH1A1 (0.53) ABL1RIN1ALDH1A1GAAGFER
SCHEMBL31053221 0.83 RAB9A (0.46) ABL1RIN1ALDH1A1KMT2AMEN1
SCHEMBL20773247 0.83 RAB9A (0.46) ABL1RIN1ALDH1A1KMT2AMEN1
SCHEMBL849433 0.81 CA2 (0.47) ABL1RIN1ALDH1A1GAAKMT2A
SCHEMBL1725721 0.81 MTNR1A (0.45) ABL1RIN1ALDH1A1GAAGFER
SCHEMBL5239543 0.79 POLB (0.44) ABL1RIN1ALDH1A1GAAKMT2A
SCHEMBL4944685 0.79 KDM4E (0.50) ALDH1A1GAAKMT2AMEN1MAPT
SCHEMBL30354606 0.79 KDM4E (0.50) ALDH1A1GAAKMT2AMEN1MAPT
SCHEMBL18524342 0.75 ALDH1A1 (0.53) ABL1RIN1ALDH1A1GAAGFER
SCHEMBL19675576 0.74 L3MBTL1 (0.49) ALDH1A1KMT2AMEN1L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3252050-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 EP disclosed
EP-3252049-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 EP disclosed